procarbazine has been researched along with Substance-Related Disorders in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Toxic effects resulted when procarbazine, a drug of this class, was used in treating a child with a CNS tumor." | 1.28 | Monoamine oxidase inhibitor toxicity. ( Pack, R; Pfefferbaum, B; van Eys, J, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pfefferbaum, B | 1 |
| Pack, R | 1 |
| van Eys, J | 1 |
1 other study available for procarbazine and Substance-Related Disorders
| Article | Year |
|---|---|
Monoamine oxidase inhibitor toxicity.
Topics: Brain Neoplasms; Child; Female; Glioma; Humans; Procarbazine; Substance-Related Disorders | 1989 |